肾移植后血液系统疾病的诊治综述
本文为综述,系统梳理肾移植术后可能出现的多种血液系统异常,涵盖从贫血、血细胞减少到治疗相关骨髓增生异常、急性髓系白血病及移植后淋巴增殖性疾病等。文中结合最新诊断与管理策略,并指出既往文献多聚焦于移植后淋巴增殖性疾病。
要点
- 肾移植受者血液系统并发症涉及免疫抑制、CKD进展与排斥反应等多重因素。
- 需关注从良性贫血到骨髓增生异常、急性髓系白血病及血栓性微血管病等谱系。
- 综述强调对移植后各类血液学异常进行及时诊断与规范管理。
核心结论
- 肾移植术后可发生从贫血、血细胞减少到骨髓增生异常、急性髓系白血病、移植后淋巴增殖性疾病、血栓性微血管病及噬血细胞综合征等一系列血液系统疾病,需结合最新诊断与管理策略予以识别和处理。
研究设计与样本
- 本文为综述,围绕肾移植术后多种血液系统问题的诊断与管理进行汇总,未报告具体检索范围与样本量。
主要发现
- 移植后血液系统异常谱系广泛,可从相对良性贫血、血细胞减少延伸至治疗相关骨髓增生异常和急性髓系白血病。
- 移植后淋巴增殖性疾病为文献关注重点,血栓性微血管病与噬血细胞综合征虽罕见但致命。
临床怎么用
- 肾内科医生应提高对肾移植术后血液系统并发症的识别意识,覆盖贫血、铁缺乏到罕见恶性血液病,并依据最新诊断与管理策略处理。
局限性
- 为叙述性综述,原文未报告系统检索策略、纳入标准及证据等级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Transplantation offers cure for some haematological cancers, end-stage organ failure, but at the cost of long-term complications. Renal transplantation is the best-known kidney replacement therapy and it can prolong end-stage renal disease patient lives for decades. However, patients after renal transplantation are at a higher risk of developing different complications connected not only with surgical procedure but also with immunosuppressive treatment, chronic kidney disease progression and rejection processes. Various blood disorders can develop in post-transplant patients ranging from relatively benign anaemia through cytopenias to therapy-related myelodysplasia and acute myeloid leukaemia (AML) and post-transplant lymphoproliferative disorders followed by a rare and fatal condition of thrombotic microangiopathy and haemophagocytic syndrome. So far literature mainly focused on the post-transplant lymphoproliferative disease. In this review, a variety of haematological problems after transplantation ranging from rare disorders such as myelodysplasia and AML to relatively common conditions such as anaemia and iron deficiency are presented with up-to-date diagnosis and management.
引用
- Malyszko J, Basak G, Batko K, et al. Haematological disorders following kidney transplantation. Nephrol Dial Transplant. 2022. PMID: 33150431. doi:10.1093/ndt/gfaa219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。